HAMLET Complex Selective Tumor Cell Killing
Solution Overview
Problem
Colon cancer remains a significant therapeutic challenge due to late detection and limited treatment options, with over 80% of sporadic and hereditary colorectal tumors showing loss of APC function, leading to invasive tumors and high mortality rates.
Innovation Solution
A biologically active complex comprising a partially unfolded polypeptide, such as alpha-lactalbumin or lysozyme, combined with a fatty acid or lipid, is administered orally to target and kill tumor cells in the gastrointestinal tract, effectively reducing tumor formation and size, and has been shown to have prophylactic and therapeutic effects in genetically susceptible mice.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional cancer treatments are used, then tumor cells are killed, but healthy cells are also damaged and treatment options are limited
Solution Approach 1:
The patent applies local quality by creating a treatment that specifically targets tumor cells through their unique vulnerability to unfolded protein-fatty acid complexes, while healthy cells with proper protein folding mechanisms remain unaffected. This is achieved by administering HAMLET (human alpha-lactalbumin made lethal to tumor cells) which exploits the differential protein folding capacity between transformed and normal cells.
Solution Approach 2:
The patent utilizes parameter changes by altering the physical state of the alpha-lactalbumin protein from its native folded conformation to an unfolded conformation through pH adjustment and heat treatment. This conformational change creates a biologically active complex with fatty acids that selectively kills tumor cells, transforming an inactive protein into a potent anticancer agent.
2Reliability
If early detection methods are implemented, then survival rate improves, but detection precision for early-stage tumors remains challenging
Solution Approach 1:
The patent applies preliminary action by using HAMLET treatment to prevent and reduce tumor formation in high-risk individuals before invasive cancer develops. The treatment targets pre-cancerous lesions and early-stage tumors, eliminating them before they become detectable by conventional imaging methods, thereby improving survival rates through preventive intervention.
3Productivity
If invasive treatment procedures are performed, then tumor removal is effective, but treatment complexity and patient burden increase
Solution Approach 1:
The patent replaces mechanical surgical intervention with a biochemical treatment approach. Instead of using surgical instruments to physically remove tumors, the invention employs HAMLET complexes that chemically induce tumor cell death through protein unfolding and membrane disruption, thereby eliminating the need for complex surgical procedures while maintaining effectiveness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The complex, known as HAMLET, demonstrates selective killing of tumor cells while sparing healthy cells, reducing tumor burden and increasing survival in APCmin mouse models, and has potential as a new approach for colon cancer prevention and treatment, particularly in individuals with genetic predisposition.
Implementation Method 1
A biologically active complex comprising a partially unfolded polypeptide, such as alpha-lactalbumin or lysozyme, combined with a fatty acid or lipid
Implementation Method 2
The complex, known as HAMLET, demonstrates selective killing of tumor cells while sparing healthy cells
Data Source
AI summary
A biologically active complex comprising a polypeptide having the sequence of a naturally occurring protein or a variant thereof, wherein said polypeptide is at least partially unfolded as compared to the said naturally occurring protein for example as a result of a modification of at least one cysteine residue; or a peptide of up to 50 amino acids; and a fatty acid or lipid or a salt thereof, for use in prophylactic treatment of cancers, in particular of the gastrointestinal tract. Compositions that may comprise the complex and have use as nutraceuticals are obtainable from milk or milk fractions and form a further aspect of the invention.Methods of treatment in particular for the prevention of cancer form a further aspect of the invention.



